(254 days)
Not Found
No
The device description focuses on the physical components and function of a nasal mask for CPAP therapy, with no mention of software, algorithms, or data processing that would indicate AI/ML.
Yes
The device is intended for use with CPAP devices for the treatment of obstructive sleep apnea, which is a medical condition. Therefore, it is a therapeutic device.
No
Explanation: The device is a nasal mask used with CPAP devices for the treatment of obstructive sleep apnea. It does not perform any diagnostic functions or gather diagnostic information.
No
The device description clearly outlines physical components made of polycarbonate and silicone, and describes a mask intended for external placement on the nose, which is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Tiara Medical Systems Advantage II Nasal Mask is a physical device used externally on the patient's face to deliver positive airway pressure. It does not analyze any biological samples.
- Intended Use: The intended use is for the treatment of obstructive sleep apnea by delivering positive airway pressure, not for diagnostic testing.
Therefore, this device falls under the category of a medical device used for treatment, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Tiara Medical Systems Advantage II Nasal Mask is intended to be used with continuous positive airway pressure devices (CPAP); operating at or above 3 cmH2O for the treatment of obstructive sleep apnea. The mask is intended for single patient use and can be used in the home or in a hospital/institutional environment. The mask is to be used on adult patients (>30Kg) for whom continuous positive airway pressure has been prescribed.
Product codes (comma separated list FDA assigned to the subject device)
BZD
Device Description
The Tiara Medical Systems Advantage II™ Nasal Mask is an externally placed mask covering the nose. The mask of systems heal such that positive pressure from a positive pressure source is directed of the patient's nose. It is held in place with an adjustable headgear. It may be cleaned with mild soap and water. The cleaning process requires limited disassembly.
The mask consists of a molded polycarbonate shell with a soft, resilient silicone skin-contacting rille mask conforms to the patient's facial features. A silicone forehead cushion is available for added comfort.
The mask connects to a conventional air delivery hose between the mask and the positive airway The mask connecto to a conventional an polycarbonate vented elbow/swivel . The elbow/swivel pressure source the mask with a polyethylene split "c" ring. The built in vent slots (2) are located attacres to the from of the make with a perfect's face and chest, and eliminate the need for a separate exhalation device. The vent slots may be visually checked for obstruction prior to use.
Canadation access is available in a variety of sizes to fit a broad range of facial structures, and attaches to the mask via slots contained within the shell.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Nose
Indicated Patient Age Range
Adult patients (>30Kg)
Intended User / Care Setting
Home or in a hospital/institutional environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Design verification tests were performed on the TMS Advantage II Nasal Mask as a result of risk design vehilouten tools word portunities were verified to meet acceptance criteria. Tiara Medical andison and product opeditions have no impact on the safety and efficacy of the device. Oystems had actornined in this submission is substantially equivalent to the predicate device, and complies with the applicable standards referenced in the "FDA Reviewer Guidance for Premarket Notifications," November 1993."
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5905 Noncontinuous ventilator (IPPB).
(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).
0
Additional Requested Information, K031935 Section 510(k) Notification, Amended Submission TMS Advantage IITM ATTACH 040302-1
Tiara Medical Systems, Inc. 14414 Detroit Ave., Ste. 205 Lakewood, OH 44107
MAR - 3 2004
Attachment 1 – 510(k) Summary of Safety and Effectiveness [As required by 21 CFR 807.92(c)]
| Submitter Name: | Tiara Medical Systems, Inc. |
|---|---|
| Submitter Address : | 14414 Detroit Ave. Ste. 205 Lakewood, OH 44107 |
| Contact Person: | Geoffrey Sleeper |
| Phone Number: | (216) 521-1220 |
| Fax Number: | (216) 521-1399 |
| Date Prepared: | June 2003 |
| Device Trade Name: | Advantage II |
| Device Common Name: | Nasal Mask |
| Classification Name: | Ventilator, Noncontinuous (Respirator), 73BZD |
| Predicate devices: | TMS Advantage Series, K012207, |
| Sullivan AutoSet Nasal CPAP System (includes ResMed Protoge) | |
| K980721 | |
| Reason for submission: | Modification to design, labeling |
Device Description:
Device Dooription.
The Tiara Medical Systems Advantage II™ Nasal Mask is an externally placed mask covering the nose The nation of oyetems heal such that positive pressure from a positive pressure source is directed of the patient's nose. It is held in place with an adjustable headgear. It may be cleaned with mild soap and water. The cleaning process requires limited disassembly.
The mask consists of a molded polycarbonate shell with a soft, resilient silicone skin-contacting rille mask conforms to the patient's facial features. A silicone forehead cushion is available for added comfort.
The mask connects to a conventional air delivery hose between the mask and the positive airway The mask connecto to a conventional an polycarbonate vented elbow/swivel . The elbow/swivel pressure source the mask with a polyethylene split "c" ring. The built in vent slots (2) are located attacres to the from of the make with a perfect's face and chest, and eliminate the need for a separate exhalation device. The vent slots may be visually checked for obstruction prior to use.
Canadation access is available in a variety of sizes to fit a broad range of facial structures, and attaches to the mask via slots contained within the shell.
Intended Use:
The Tiara Medical Systems Advantage II Nasal Mask is intended to be used with continuous positive rine fiara modifical Gyotonio have a cabove 3 cmH20 for the treatment of obstructive sleep apnea. The mask is intended for single patient use and can be used in the home or in a hospital/institutional environment. The mask is to be used on adult patients (>30Kg) for whom continuous positive airway pressure has been prescribed.
Substantial Equivalence/ Device Technological Characteristics and Comparison to Predicate Device(s):
The modified device has the following similarities to the previously cleared predicate devices:
- same intended use -
- same operating principle -
- same technology, same materials in contact with patient's skin -
- same manufacturing process -
Design verification tests were performed on the TMS Advantage II Nasal Mask as a result of risk Design vehilouten tools word portunities were verified to meet acceptance criteria. Tiara Medical andison and product opeditions have no impact on the safety and efficacy of the device. Oystems had actornined in this submission is substantially equivalent to the predicate device, and complies with the applicable standards referenced in the "FDA Reviewer Guidance for Premarket Notifications," November 1993."
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an emblem featuring a stylized eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans and provide essential human services.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR - 3 2004
Mr. Geoffrey Sleeper Vice President Tiara Medical Systems, Incorporated 14414 Detroit Avenue, Suite 205 Lakewood, Ohio 44107
Re: K031935
Trade Name: Advantage II Nasal Mask, Models TMS-2520 and TMS-2530 Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: January 15, 2004 Received: January 16, 2004
Dear Mr. Sleeper:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Codc of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
2
Page 2 - Mr. Geoffrey Sleeper
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as setmon CFR Part 807); labeling (21 CFR Part 001); good manation (21 CFR Part 820); and if applicable, the electronic
forth in the quality systems (QS) regulation (21 CFR 1000 (1050 forth in the quality systems (Sections (Sections 531-542 of the Act); 21 CFR 1000-1050.
product radiation control provisions (Sections 531-542 of the Actived in your Section product radiation control provisions (Sections 551 312 ce as described in your Section 510(k)
This letter will allow you to begin marketing your device of your device to Jega This letter will allow you to ocgin marketing of substantial equivalence of your device to a legally premarket notification. The PDA Iniding of substantial of your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice for your ac not one of the regulation entitled.
contact the Office of Compliance at (301) 594-4646. Also, please note the move abtain contact the Office of Comphance at (301) 55 (21CFR Patt 807.97). You may obtain "Misbranding by relefence to premarks. Iouities. In the Act from the Division of Small
other general information on your responsibilities under the Act from when (800) 638, 2 other general information on your responsion.com in toll-free number (800) 638-2041 or
Manufacturers, International and Consumer Assistance at its toll-idemansin html Manufacturers, International and Consumer Pleases agov/odrh/dsma/dsmamain.html.
Sincerely yours,
Ove
Chin Lin, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
INDICATIONS FOR USE
[510(k)] Number: K031935
Device Name: Tiara Medical Systems Advantage II™ Nasal Mask
Indications For Use:
The Tiara Medical Systems Advantage II Nasal Mask is intended bo be used with ontinuous The Tiala Medical Oystems Auvantage II Nacariting at or above 3 cmH20 for the treatment of positive alway pressure devices (OF Ar ); operating at on early of the mast on be used in the obstructive sleep apriled. The mask is likendou for Single patter on adult patients nome of in a noophalities spositive airway pressure has been prescribed.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-the-Counter Use_ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Lottkehm
n Sign-Off) on of Anesthesiology, General Hospital. Infection Control. Den
510(k) Number: K031935